Kelly Shi
Stock Analyst at Jefferies
(3.19)
# 1,090
Out of 5,090 analysts
32
Total ratings
45.16%
Success rate
17.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $77.26 | -0.33% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $204.00 | -27.45% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $38.77 | -27.78% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $18.31 | +140.31% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $10.36 | +44.79% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $10.92 | +376.19% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.36 | +221.10% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $29.91 | -36.48% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $205.44 | -4.60% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $3.36 | +525.00% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $20.32 | +82.09% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.34 | +156.41% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $102.52 | -20.99% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $24.69 | +41.76% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.55 | +1,311.76% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $14.90 | +7.38% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $66.62 | -39.96% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $17.41 | +14.88% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.29 | +249.34% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.53 | +4,954.29% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.22 | +265.68% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.40 | +1,025.00% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.99 | +1,558.29% | 1 | Mar 8, 2021 |
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $77.26
Upside: -0.33%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $204.00
Upside: -27.45%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $38.77
Upside: -27.78%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $18.31
Upside: +140.31%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $10.36
Upside: +44.79%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $10.92
Upside: +376.19%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.36
Upside: +221.10%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $29.91
Upside: -36.48%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $205.44
Upside: -4.60%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $3.36
Upside: +525.00%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $20.32
Upside: +82.09%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.34
Upside: +156.41%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $102.52
Upside: -20.99%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $24.69
Upside: +41.76%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.55
Upside: +1,311.76%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $14.90
Upside: +7.38%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $66.62
Upside: -39.96%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $17.41
Upside: +14.88%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.29
Upside: +249.34%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.53
Upside: +4,954.29%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.22
Upside: +265.68%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.40
Upside: +1,025.00%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.99
Upside: +1,558.29%